Cited 5 times in
2LBA Late Breaking - Pivotal topline data from the phase 1/2 TRIDENT-1 trial of repotrectinib in patients with ROS1+ advanced non-small cell lung cancer (NSCLC)
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 조병철 | - |
dc.date.accessioned | 2023-03-21T07:16:56Z | - |
dc.date.available | 2023-03-21T07:16:56Z | - |
dc.date.issued | 2022-10 | - |
dc.identifier.issn | 0959-8049 | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/193290 | - |
dc.description.statementOfResponsibility | restriction | - |
dc.language | English | - |
dc.publisher | Elsevier Science Ltd | - |
dc.relation.isPartOf | EUROPEAN JOURNAL OF CANCER | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.title | 2LBA Late Breaking - Pivotal topline data from the phase 1/2 TRIDENT-1 trial of repotrectinib in patients with ROS1+ advanced non-small cell lung cancer (NSCLC) | - |
dc.type | Article | - |
dc.contributor.college | College of Medicine (의과대학) | - |
dc.contributor.department | Dept. of Internal Medicine (내과학교실) | - |
dc.contributor.googleauthor | B.C. Cho | - |
dc.contributor.googleauthor | J. Lin | - |
dc.contributor.googleauthor | D.R. Camidge | - |
dc.contributor.googleauthor | V. Velcheti | - |
dc.contributor.googleauthor | B. Solomon | - |
dc.contributor.googleauthor | S. Lu | - |
dc.contributor.googleauthor | K.H. Lee | - |
dc.contributor.googleauthor | S.W. Kim | - |
dc.contributor.googleauthor | S. Kao | - |
dc.contributor.googleauthor | R. Diadziuskzko | - |
dc.contributor.googleauthor | M. Beg | - |
dc.contributor.googleauthor | M. Nagasaka | - |
dc.contributor.googleauthor | E. Felip | - |
dc.contributor.googleauthor | B. Besse | - |
dc.contributor.googleauthor | C. Springfeld | - |
dc.contributor.googleauthor | S. Popat | - |
dc.contributor.googleauthor | J. Wolf | - |
dc.contributor.googleauthor | D. Trone | - |
dc.contributor.googleauthor | S. Stopatschinskaja | - |
dc.contributor.googleauthor | A. Drilon | - |
dc.identifier.doi | 10.1016/S0959-8049(22)00812-7 | - |
dc.contributor.localId | A03822 | - |
dc.relation.journalcode | J00809 | - |
dc.identifier.eissn | 1879-0852 | - |
dc.identifier.url | https://www.sciencedirect.com/science/article/pii/S0959804922008127 | - |
dc.contributor.alternativeName | Cho, Byoung Chul | - |
dc.contributor.affiliatedAuthor | 조병철 | - |
dc.citation.volume | 174 | - |
dc.citation.number | Suppl.1 | - |
dc.citation.startPage | S1 | - |
dc.citation.endPage | S2 | - |
dc.identifier.bibliographicCitation | EUROPEAN JOURNAL OF CANCER, Vol.174(Suppl.1) : S1-S2, 2022-10 | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.